IL1B and septic shock: Our results revealed that the antibody induced LPS resistance of monocytes/macrophages in vitro, showing downregulated LPS-induced production of NO, IL-1β, IL-6 and IFN-β, and conferred protection against LPS and CLP-induced septic shock, manifested as reduced inflammation and increased survival.